Task: Answer the MCQ question.
Query: Which drug exhibits a 9.911% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: Cc1nn(C(C)c2n[nH]c(=S)n2-c2cccc(Cl)c2)c(C)c1[N+](=O)[O-]
b: CCCOC(=O)CCCN1C(=O)/C(=C2\SC(=S)N(CCCC(=O)OCCC)C2=O)SC1=S
Answer: b. CCCOC(=O)CCCN1C(=O)/C(=C2\SC(=S)N(CCCC(=O)OCCC)C2=O)SC1=S
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCOC(=O)CCCN1C(=O)/C(=C2\SC(=S)N(CCCC(=O)OCCC)C2=O)SC1=S
CCCOC(=O)CCCN1C(=O)/C(=C2\SC(=S)N(CCCC(=O)OCCC)C2=O)SC1=S
propyl 4-[(5E)-4-oxo-5-[4-oxo-3-(4-oxo-4-propoxybutyl)-2-sulfanylidene-1,3-thiazolidin-5-ylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoate